An Open-Label Taste Assessment of Tricaprilin Formulated as a Powder for Reconstitution in Healthy Panelists
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 08 Oct 2018
At a glance
- Drugs Tricaprilin (Primary)
- Indications Alzheimer's disease
- Focus Adverse reactions
- Acronyms TMS
- Sponsors Cerecin
- 04 Oct 2018 According to a Cerecin media release, Accera changed its name to Cerecin.
- 27 Sep 2018 Status changed from recruiting to active, no longer recruiting.
- 11 Sep 2018 Planned End Date changed from 30 Dec 2018 to 30 Mar 2019.